Amwill Healthcare Limited IPO (Amwill Healthcare IPO) Detail

Amwill Healthcare IPO is a book built issue of Rs 59.98 crores. The issue is a combination of fresh issue of 44.04 lakh shares aggregating to Rs 48.88 crores and offer for sale of 10.00 lakh shares aggregating to Rs 11.10 crores.

Amwill Healthcare IPO bidding started from February 5, 2025 and ended on February 7, 2025. The allotment for Amwill Healthcare IPO was finalized on Monday, February 10, 2025. The shares got listed on BSE SME on February 12, 2025.

Amwill Healthcare IPO price band is set at ₹111 per share. The minimum lot size for an application is 1200. The minimum amount of investment required by retail investors is ₹1,26,000. But it is suggested to the investor to bid at the cutoff price to avoid the oversubscription senerio, which is about to ₹1,33,200. The minimum lot size investment for HNI is 2 lots (2,400 shares) amounting to ₹2,66,400.

Unistone Capital Pvt Ltd is the book-running lead manager of the Amwill Healthcare IPO, while Bigshare Services Pvt Ltd is the registrar for the issue.The market maker for Amwill Healthcare IPO is Globalworth Securities Limited.

Refer to Amwill Healthcare IPO RHP for detailed information.

Amwill Health Care Ltd Stock Quote & Charts

• Open: ₹69.60
• High – Low: ₹72.00 – ₹69.10
• Previous Close: ₹69.40
• Total Traded Value: 40,800.00
• 52 Weeks High: ₹69.50 (Feb 13, 2025)
• 52 Weeks Low: ₹84.45 (Mar 26, 2025)
• Updated On: Feb 12, 2025 4:00 PM

Amwill Healthcare IPO Details

Amwill Healthcare IPO Reservation

Amwill Healthcare IPO offers 54,03,600 shares. 10,26,000 (18.99%) to QIB, 20,53,200 (38%) to NII, 20,53,200 (38%) to RII.

Amwill Healthcare IPO Timeline (Tentative Schedule)

Amwill Healthcare IPO opens on February 5, 2025, and closes on February 7, 2025.

Amwill Healthcare IPO Lot Size

Investors can bid for a minimum of 1200 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.

Amwill Healthcare IPO Promoter Holding

Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue – Share Holding Post Issue

About Amwill Healthcare Limited

Incorporated in August 2017, Amwill Health Care Limited is a derma-cosmetic development firm that collaborates with contract manufacturers, distributors, and third-party product development agencies. This collaboration has enhanced the company’s manufacturing, packaging, and distribution capabilities.

The product portfolio of the Company is divided into two categories, namely,

1. Development of generic dermatological solutions and
2. Formulating targeted solutions for dermatological issues.

The company markets its products in Karnataka, Andhra Pradesh, and Telangana, focusing on strengthening its presence before entering new markets to build a customer base.

The company develops products for dermatological disorders, including acne, fungal infections, anti-aging, histaminic, periorbital hyperpigmentation, scabies, perspiration, trichology, and vitiligo.

As of September 30, 2024, the company has 84 employees on payroll.

Competitive Strength

• Extensive product portfolio supported by product formulation capabilities
• Provision of high-quality product development through tie-ups with contract manufacturers and prototype developers
• Well-experienced management team with proven project management and implementation skills
• Asset-light business model.

Company Financials

Amwill Healthcare Limited Financial Information (Restated)

Key Performance Indicator (KPI)

The market capitalization of Amwill Healthcare IPO is Rs 222.04 Cr.

KPI as of Sun, Mar 31, 2024.

• The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2024 that is available in RHP.
• The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of September 30, 2024 that is available in RHP.

Objects of the Issue (Amwill Healthcare IPO Objectives)

The company proposes to utilize the Net Proceeds in the following manner.

1. Funding of working capital requirements of the Company
2. Marketing and brand-building activities
3. General corporate purposes

Amwill Healthcare IPO Review May apply

[Dilip Davda]  AHL operates on a third party contract manufacturing of dermatological products on a need based formula. It posted higher margins from FY24 onwards following cost-control and tailor made high-margin products. It has emerged as an establish player in the field with user friendly quality products. Based on its recent financial performance, the issue appears fully priced. The company is operating with its asset light model in an emerging segment. Well-informed investors may park funds for the medium to long term. Read detail review…

Amwill Healthcare IPO Subscription Status (Bidding Detail)

The Amwill Healthcare IPO is subscribed 5.73 times on February 7, 2025 5:04:51 PM (Day 3). The public issue subscribed 4.77 times in the retail category, 7.8 times in the QIB category, and 5.66 times in the NII category. Check Day by Day Subscription Details (Live Status)

Total Application : 9,413

*Market Maker portion is not included to NII/HNI.

About The Author

ipoindiaa

See author's posts